Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy (AZTEK EXT)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Prostate Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT00692874
NIS-OHU-ZOL-2007/1

Details and patient eligibility

About

This is an open label, non-interventional quality of life analysis for Zoladex treated prostate cancer patients by investigator's questionnaire

Enrollment

1,646 patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Provision of informed consent
  • Early or locally-advanced prostate cancer patients on androgen deprivation therapy
  • Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment.

Exclusion criteria

  • Allergy to substance of medication
  • Prostate cancer patients with advanced disease

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems